BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 14991594)

  • 1. Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patients.
    Le Rond S; Le Maoult J; Créput C; Menier C; Deschamps M; Le Friec G; Amiot L; Durrbach A; Dausset J; Carosella ED; Rouas-Freiss N
    Eur J Immunol; 2004 Mar; 34(3):649-660. PubMed ID: 14991594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD3+CD4low and CD3+CD8low are induced by HLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance.
    Naji A; Le Rond S; Durrbach A; Krawice-Radanne I; Creput C; Daouya M; Caumartin J; LeMaoult J; Carosella ED; Rouas-Freiss N
    Blood; 2007 Dec; 110(12):3936-48. PubMed ID: 17804694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/ regulatory T cells.
    Le Rond S; Azéma C; Krawice-Radanne I; Durrbach A; Guettier C; Carosella ED; Rouas-Freiss N
    J Immunol; 2006 Mar; 176(5):3266-76. PubMed ID: 16493088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism.
    Lila N; Rouas-Freiss N; Dausset J; Carpentier A; Carosella ED
    Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12150-5. PubMed ID: 11572934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HLA-G: immunoregulatory molecule involved in allograft acceptance].
    Creput C; Durrbach A; Charpentier B; Carosella ED; Rouas-Freiss N
    Nephrologie; 2003; 24(8):451-6. PubMed ID: 14737978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of HLA-G5 secreting cells.
    Rebmann V; Busemann A; Lindemann M; Grosse-Wilde H
    Hum Immunol; 2003 Nov; 64(11):1017-24. PubMed ID: 14602230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape.
    Wiendl H; Mitsdoerffer M; Hofmeister V; Wischhusen J; Bornemann A; Meyermann R; Weiss EH; Melms A; Weller M
    J Immunol; 2002 May; 168(9):4772-80. PubMed ID: 11971028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: implications for myoblast transplantation and gene therapy.
    Wiendl H; Mitsdoerffer M; Hofmeister V; Wischhusen J; Weiss EH; Dichgans J; Lochmuller H; Hohlfeld R; Melms A; Weller M
    Brain; 2003 Jan; 126(Pt 1):176-85. PubMed ID: 12477705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells.
    Romagnani C; Pietra G; Falco M; Millo E; Mazzarino P; Biassoni R; Moretta A; Moretta L; Mingari MC
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11328-33. PubMed ID: 12167676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble HLA-G and HLA-G1 expressing antigen-presenting cells inhibit T-cell alloproliferation through ILT-2/ILT-4/FasL-mediated pathways.
    Naji A; Durrbach A; Carosella ED; Rouas-Freiss N
    Hum Immunol; 2007 Apr; 68(4):233-9. PubMed ID: 17400057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation.
    Créput C; Durrbach A; Menier C; Guettier C; Samuel D; Dausset J; Charpentier B; Carosella ED; Rouas-Freiss N
    J Hepatol; 2003 Oct; 39(4):587-94. PubMed ID: 12971970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of soluble HLA-G identifies favorable outcomes in liver transplant recipients.
    Zarkhin V; Talisetti A; Li L; Wozniak LJ; McDiarmid SV; Cox K; Esquivel C; Sarwal MM
    Transplantation; 2010 Nov; 90(9):1000-5. PubMed ID: 20814356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and immunologic aspects of the nonclassical HLA class I antigen HLA-G: evidence for an important role in the maternal tolerance of the fetal allograft.
    Moreau P; Paul P; Rouas-Freiss N; Kirszenbaum M; Dausset J; Carosella ED
    Am J Reprod Immunol; 1998 Sep; 40(3):136-44. PubMed ID: 9764357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-G has a concentration-dependent effect on the generation of an allo-CTL response.
    Kapasi K; Albert SE; Yie S; Zavazava N; Librach CL
    Immunology; 2000 Oct; 101(2):191-200. PubMed ID: 11012772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.
    Contini P; Ghio M; Poggi A; Filaci G; Indiveri F; Ferrone S; Puppo F
    Eur J Immunol; 2003 Jan; 33(1):125-34. PubMed ID: 12594841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.
    Selmani Z; Naji A; Zidi I; Favier B; Gaiffe E; Obert L; Borg C; Saas P; Tiberghien P; Rouas-Freiss N; Carosella ED; Deschaseaux F
    Stem Cells; 2008 Jan; 26(1):212-22. PubMed ID: 17932417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells secrete the immunosuppressive HLA-G molecule upon CTLA4-Ig treatment: implication in human renal transplant acceptance.
    Bahri R; Naji A; Menier C; Charpentier B; Carosella ED; Rouas-Freiss N; Durrbach A
    J Immunol; 2009 Dec; 183(11):7054-62. PubMed ID: 19915057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The soluble pool of HLA-G produced by human trophoblasts does not include detectable levels of the intron 4-containing HLA-G5 and HLA-G6 isoforms.
    Blaschitz A; Juch H; Volz A; Hutter H; Daxboeck C; Desoye G; Dohr G
    Mol Hum Reprod; 2005 Oct; 11(10):699-710. PubMed ID: 16330474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human leukocyte antigen-G, a new parameter in the follow-up of liver transplantation.
    Baştürk B; Karakayali F; Emiroğlu R; Sözer O; Haberal A; Bal D; Haberal M
    Transplant Proc; 2006 Mar; 38(2):571-4. PubMed ID: 16549178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.